Beam Therapeutics (BEAM) Earnings Date & Reports

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BEAM is expected to report earnings to rise 11.01% to -121 cents per share on May 13

Beam Therapeutics BEAM Stock Earnings Reports

Q1'25

Est.

$-1.21

Q4'24

Beat

by $0.18

Q3'24

Beat

by $0.01

Q2'24

Beat

by $0.02

Q1'24

Beat

by $0.20

The last earnings report on February 25 showed earnings per share of -109 cents, beating the estimate of -126 cents. With 1.78M shares outstanding, the current market capitalization sits at 2.04B.

View a ticker or compare two or three

Compare

BEAM